Effects of MG132 on FNmRNA expression in early diabetic nephropathy rats

Chinese Pharmacological Bulletin

Volumn 27, Issue 12, 2011, Pages 1773-1774

  Wang, Yu Rong ^a,b   Xu, Yong ^a   Fang, Xiang Ming ^b   Liu, Yun ^b  

^a SOUTHWEST MEDICAL UNIVERSITY   (China)

^b MIANYANG CENTRAL HOSPITAL   (China)

Author keywords

Diabetic nephropathy; FN; Protease inhibitors; Renal fibrosis; UAER; Up Ucr

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DIABETIC NEPHROPATHY; DRUG EFFECT; NONHUMAN; PROTEIN EXPRESSION; RAT;

EID: 84863131688     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1001-1978.2011.12.034     Document Type: Article

References (7)

1. Mark D, Molitch E, Ralph A, et al. Nephropathy in diabetes[J]. Diabetes Care, 2004,27(1):79-83.
2. Yu M, Zhou H H, Liu Z Q. Progress in related genes of diabetic nephropathy[J]. Chin Pharmacol Bull, 2008,24(11):1419-22.
3. Mason R M, Wahab N A. Extracellular matrix metabolism in diabetic nephropathy[J]. J Am Soc Nephrol, 2003,14:1358-73. (Pubitemid 36519197)
4. Qian Y, Feldman E, Pennathur S, et al. From fibrosis to sclerosis mechanisms of glomerulosclerosis in diabetic nephropathy[J]. Diabetes, 2008,57:1439-45.
5. Zhang H J, Zhao J B, Li P. Progress in the study on animal model of diabetic nephropathy[J]. Chin Pharmacol Bull, 2008,24(7):845-8.